Precision BioSciences CEO RSU Vesting Signals Long‑Term Confidence Amid CRISPR Milestones
Precision BioSciences insider activity shows CEO RSU vesting and leadership buying, aligning long‑term value with CRISPR‑based therapy progress and FDA Fast‑Track milestones.
4 minutes to read